1. Home
  2. SCWO vs XBIT Comparison

SCWO vs XBIT Comparison

Compare SCWO & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 374Water Inc.

SCWO

374Water Inc.

HOLD

Current Price

$0.24

Market Cap

72.8M

Sector

Utilities

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.54

Market Cap

73.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCWO
XBIT
Founded
2021
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Pharmaceuticals and Biotechnology
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.8M
73.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SCWO
XBIT
Price
$0.24
$2.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.2M
66.2K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,910,340.00
N/A
Revenue This Year
$5,945.19
N/A
Revenue Next Year
$106.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
508.52
N/A
52 Week Low
$0.16
$2.09
52 Week High
$1.09
$6.82

Technical Indicators

Market Signals
Indicator
SCWO
XBIT
Relative Strength Index (RSI) 43.35 52.78
Support Level $0.21 $2.40
Resistance Level $0.30 $2.55
Average True Range (ATR) 0.03 0.14
MACD 0.00 0.01
Stochastic Oscillator 50.35 57.89

Price Performance

Historical Comparison
SCWO
XBIT

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: